Skybizz

$cytk what & when is Omecamtive news expected?

stocktwits 47 minutes ago

Rogue1

Mid-day check: $FMCC $fnma strong, $clnt killed it, $Amd and $bbry flat, $cytk flat before shareholder mtg AC for Ome or RS news and rocket?

stocktwits 1 hour 8 minutes ago

kgpittm

My top 5 holdings based on current value: $CYTK $INO $COOL $RNN $ONTY

stocktwits 1 hour 31 minutes ago

tariqrahiman

@1.15 loaded more.. but $CYTK being so shaky for 2 weeks

stocktwits 2 hours ago

BiotechMaster

At least $CYTK has sugar daddie $AMGN helping out. Should get a nice milestone payment soon.

stocktwits 10 hours 46 minutes ago

BiotechMaster

All microcap biotechs, $CYTK included, have terrible finances. It is the nature of the beast. Microcap biotechs expenses>>revenue. Always.

stocktwits 10 hours 47 minutes ago

BiotechMaster

If Ome succeeds, $CYTK will do well r/s or no r/s. If Ome fails, $CYTK will tank r/s or no r/s. Simple.

stocktwits 10 hours 49 minutes ago

BiotechMaster

$CYTK Like all microcap biotechs, success will depend upon success of drugs in their pipeline, R/S or not.

stocktwits 10 hours 50 minutes ago

BiotechMaster

If $CYTK >$5, then large investors/mutual funds can buy stock.

stocktwits 10 hours 51 minutes ago

BiotechMaster

$CYTK Should be an interesting meeting today. Would place odds of R/S at 50:50. If they do, they should do at least a 5:1.

stocktwits 10 hours 52 minutes ago

BiotechMaster

$CYTK Relaxin preps the body for childbirth: loosens up joints/ligaments. In older people, would cause more falls/fractures/metastatic CA.

stocktwits 15 hours ago

BiotechMaster

$CYTK Much focus on relaxin, which is a joke. There is a reason 70-year old women do not give birth: their bodies cannot tolerate it.

stocktwits 15 hours 3 minutes ago

BiotechMaster

$CYTK Omecam superior to relaxin, ularitide, clevidipine, levosimendan. Others DO NOT increase efficiency of heart like Omecam. IMHO

stocktwits 15 hours 7 minutes ago

BiotechMaster

$CYTK Omecam is the most promising heart failure drug currently in development. Period. Increases EF/SV/CO. Decreases HR/BP. No arrhythmias.

stocktwits 15 hours 9 minutes ago

BiotechMaster

$CYTK Usually give multiple talks if large, late phase (P3) study.

stocktwits 15 hours 17 minutes ago

BiotechMaster

$CYTK Usually, just have one poster and one talk. Funny they will give 3 talks. Do not want to present same data 3 times. Curious.

stocktwits 15 hours 20 minutes ago

BiotechMaster

Info on Omecamtiv presentations on Heart Failure Congress 2013 website. Interesting $CYTK will give THREE talks on Ome.

stocktwits 15 hours 23 minutes ago

BiotechMaster

@jamesdyer $CYTK You can find info on Heart Failure Congress 2013 website

stocktwits 15 hours 25 minutes ago

BiotechMaster

$CYTK Will have 3 talks,1 poster session @ Euro cardio meeting May 26-27. Would be perfect if they present new P2b ATOMIC data.

stocktwits 17 hours 4 minutes ago

Macroeconomics

@Rogue1 Whatever it is... Hopefully, it causes some movement in the price. Undervalued right now... Needs to move up. $CYTK

stocktwits 17 hours 31 minutes ago

Rogue1

$CYTK Annual meeting is tomorrow @ 1:30pm pacific. Update on Ome?

stocktwits 23 hours 54 minutes ago

Rogue1

@Macroeconomics It has to wait till my profits from solars settle, so I can add while it runs up. In other words, 3+ days. ;-) $cytk

stocktwits Tue May 21, 2013 12:58 pm EDT

Macroeconomics

$CYTK has been quiet for a while. When is this thing moving back to $1.40

stocktwits Tue May 21, 2013 10:37 am EDT

Keynesonomics

$CYTK could receive as much as $300 mil in milestones PRIOR to launch & an equal amount following launch.Payments r inevitable catalysts

stocktwits Mon May 20, 2013 11:46 pm EDT

BiotechMaster

$AMGN is listening to $CYTK s story/research platform, Wall St is not. If Ome succeeds, $CYTK will become a perfect $AMGN takeover target

stocktwits Mon May 20, 2013 11:34 pm EDT